-
Innovation Ranking
NewInnovation Ranking – The Carlyle Group LP
The Carlyle Group Inc. (Carlyle) is a global alternative asset management, private equity, and financial services firm. The group advises specialized investment funds and other investment vehicles that invest across various industries, geographies, asset classes, and investment strategies. Carlyle has expertise in industries including aerospace, defense and government services, consumer and retail, energy, financial services, healthcare, industrial, real estate, technology and business services, telecommunications and media, and transportation. Its investors include public and private pension funds, high net-worth individuals, insurance...
-
Innovation Ranking
NewInnovation Ranking – Icahn Enterprises LP
Icahn Enterprises LP (Icahn) carries out operations in investment, automotive, energy, gaming, food packaging, real estate, and home fashion businesses. It offers non-edible cellulosic casings for small-diameter meats and non-edible fibrous casings for processed meat. Icahn provides automotive repair and maintenance services. The company also manufactures petroleum and nitrogen fertilizers, and real estate operations. It offers aftermarket services and parts and accessories to its automotive customers. The company operates in America, Asia, and Europe. Icahn is headquartered in Sunny Isles...
-
Innovation Ranking
NewInnovation Ranking – Brookfield Business Partners LP
Brookfield Business Partners LP (BBP), a subsidiary of Brookfield Corp, is a provider of investment services. It invests in industrial, infrastructure services and business services sectors. The company's infrastructure services include services to the offshore oil production industry and nuclear power generation industry. BBP's business services comprise entertainment, financing services, residential mortgage insurance services, healthcare services, road fuel distribution, marketing, real estate and construction services. It also invests in corporate cash and liquidity management, water and wastewater services, natural gas...
-
Innovation Ranking
NewInnovation Ranking – Alliance Resource Partners LP
Alliance Resource Partners LP (ARLP) is a coal mining company that is engaged in the production and marketing of coal. It produces a diverse range of thermal and metallurgical coal with varying sulfur and heat contents. Alliance supplies coal for major US utilities and industrial users. The company distributes its product by rail, barge and truck. It operates mining complexes in Indiana, Illinois, Kentucky, Pennsylvania, Maryland and West Virginia. The company also has mineral interests in major oil and gas...
-
Innovation Ranking
NewInnovation Ranking – Calumet Specialty Products Partners LP
Calumet Specialty Products Partners, L.P. (Calumet or 'the company') is an independent producer of hydrocarbon products. Calumet’s portfolio includes asphalt, base oils and lubricants, jet fuel, diesel, food-grade lubricants, gasoline specialty waxes, and other products. The company also provides greases, gelled hydrocarbons, natural petroleum sulfonates, cable fillers, polyester-based synthetic lubricants, and industrial white oils among others. Calumet offers its products under brands such as Bel-Ray, TruFuel, and Royal Purple. Calumet’s production plants and selling centers are located across the US....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Melanoma Drug Details: LP-184 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-118 in Myelofibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-118 in Myelofibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-118 in Myelofibrosis Drug Details: LP-118 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-184 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-184 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-184 in Solid Tumor Drug Details: LP-184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-108 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-108 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-108 in Myelodysplastic Syndrome Drug Details: LP-108 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-118 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-118 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-118 in Myelodysplastic Syndrome Drug Details: LP-118 is under development for the...